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ABSTRACT 
MicroRNAs (miRNAs) are short, non-coding RNAs involved in the regulation of 
several processes associated with inflammatory diseases and infection. Bacterial infection 
modulates miRNA expression to subvert innate immune response. In this study, we analyzed 
bacterial modulation of miRNAs in bone-marrow-derived macrophages (BMMs), in which 
activity was induced by infection with Porphyromonas gingivalis (Pg) through a microarray 
analysis. Several miRNA expressions levels were modulated 3 hours post infection (at a 
multiplicity of infection (MOI) of 25). A bioinformatics analysis was performed to further 
identify pathways related to the innate immune host-response pathways that are under the 
influence of the selected miRNAs. To assess the effects of the identified miRNAs on cytokines 
secretion (pro-inflammatory TNF-α and anti-inflammatory IL-10), BMMs were transfected 
with selected miRNAs mimics or inhibitors. Transfection with mmu-miR-155 and mmu-miR-
2137 did not modify TNF-α secretion while their inhibitors increased it. Inhibitors of mmu-
miR-2137 and mmu-miR-7674 increased the secretion of the anti-inflammatory IL-10. In Pg-
infected BMMs, mmu-miR-155-5p significantly decreased TNF-α secretion while inhibitor of 
mmu-miR-2137 increased IL-10 secretion. In vivo, in a Pg-induced calvarial bone resorption 
mouse model, injection of mmu-miR-155-5p or anti-mmu-miR-2137 reduced the size of the 
lesion significantly. Furthermore, anti-mmu-miR-2137 significantly reduced inflammatory 
cell infiltration, osteoclast activity and bone loss. Bioinformatics analysis demonstrated that 
 vi 
pathways related to cytokines and chemokines related pathways but also osteoclast 
differentiation may be involved in the observed effects. The study highlights the potential 
therapeutic merits of targeting mmu-miR-155-5p and mmu-miR-2137 to control inflammation 
induced by Pg infection. 
To assess the regenerative process in the same animal model, we aimed to compare the 
effect of Bone Morphogenic Protien 2 (BMP2), Platelets Rich Plasma (PRP), Leukocyte-
Platelets Rich Fibrin (L-PRF), and Polygucosamine (PGIcNAc) on bone formation in critical 
size bone defects in mice. One-hundred-thirty-eight mice were divided into 23 groups (n=6), 
negative control, different combinations of the PGIcNAc with or without of BMP2, Collagen 
Sponge (SurgiFoam), PRP, and L-PRF. The 5mm defect, then, was allowed to heal. After six 
weeks, samples were analyzed for bone formation utilizing radiographs, H&E staining, 
alkaline phosphatase staining. Our results show that BMP2 were able to produce 90-95% 
healing of critical size defects after six weeks histologically and radiographically. However, 
SurgiFoam, PRP and L-PRF with or without PGIcNAc were able to close 60% of the original 
defect. This study supports that BMP2 is more effective for bone regeneration than SurgiFoam, 
PRP, L-PRF and PGIcNAc. 
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1. INTRODUCTION 
1.1.Modulation of Inflammation 
Periodontitis (PD) is a common chronic inflammatory disease which can induce the 
destruction of tooth-supporting tissues (Pihlstrom et al., 2005; Hajishengallis & Lamont, 2014) 
and has been linked to several systemic diseases, such as cardiovascular diseases (Zhou & 
Amar, 2007; Hajishengallis, 2015). The pathogenesis of PD is associated with a dysbiosis of 
periodontal microbiota. This dysbiosis is characterized by a shift from a symbiotic microbial 
community to a pathogenic one which is mainly composed of anaerobic bacteria, resulting in 
an alteration of the host-microbe cross-talk (Hajishengallis, 2015). Porphyromonas gingivalis 
(Pg) is a gram-negative anaerobic bacterium, considered as a keystone-pathogen in PD 
(Hajishengallis, 2015). It produces several virulence factors such as lipopolysaccharides (LPS) 
and fimbriae, the later facilitating the invasion of different cell types, such as endothelial 
(Rodrigues et al., 2012) and epithelial cells (Kato et al., 2014; Morandini et al., 2014). Several 
mechanisms are induced by Pg such as modulation of gene and protein expression, thereby 
compromising immune function at the periodontal level (Zhou et al., 2007; Hajishengallis et 
al., 2014). For instance, in endothelial cells, Pg, through its LPS, not only increases secretion 
of several pro-inflammatory cytokines including TNF-α and IL-6 but also of anti-
inflammatory cytokines such as IL-10 demonstrating the complexity of the cell’s response to 
infection (Bugueno et al., 2016). These inflammatory processes and immune responses 
activated after bacterial infection are also responsible for tissue destruction.  
 Macrophages are pivotal cells in the host-response due to their direct contact with 
infectious agents or their byproducts (Giannobile, 2008; Kebschull & Papapanou, 2015). These 
cells are often found in chronic periodontitis diseased tissues (Gemmell et al., 2001) and 
represent an important fraction of the total inflammatory cell population (Okada & Murakami, 
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1998). Pg has been demonstrated to activate macrophages (Yu et al., 2010; Kebschull et al., 
2015), known to be able to invade macrophages (Olczak et al., 2015) and to induce an 
important modulation of gene expression resulting in the synthesis of several mRNAs related 
to signaling, apoptosis, cytokine receptors, and chemokine pathways (Zhou et al., 2007; Yu et 
al., 2010). Post-transcriptional regulation may occur specifically through microRNAs 
(miRNAs). It is important to note that it is not known if the miRNA modulations induced by 
Pg have biological consequences. 
Recognized as critical mediators in gene expression, miRNAs are short, non-coding 
RNAs involved in many physiological and pathological processes (Zhou et al., 2007; 
Hajishengallis et al., 2014; Hosin et al., 2014). In recent years, several roles have been 
described for miRNAs in numerous inflammatory diseases, such as cardiovascular diseases, 
diabetes, obesity, arthritis and PD (Marques-Rocha et al., 2015). Partially complementary to 
the sequence of mRNAs in the 3’ UTR region, miRNAs could down-regulate gene expression 
at the post-transcriptional level (Simo et al., 2015). However, the identification of miRNA 
expression and the roles of miRNAs in inflammatory and infectious diseases are not fully 
understood. The analysis of the modulation of miRNA expression in infectious and 
inflammatory diseases may lead to the identification of new potential biomarkers and 
therapeutics (Marques-Rocha et al., 2015). 
It is important to note that even though natural miRNA possess short half-life. Synthetic 
miRNA has been successfully developed to be more stable and able to avoid the activation of 
endogenous RNase. The added stability to the synthetic miRNA has been obtained through a 
chemical modification in the backbone. Such chemical modifications of the antisense includes 
2′-O-oligonuclmethyl, methoxyethyl nucleotides, 2′-F nucleotides and phosphorothioate 
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backbone). Modified oligonucleotides have been shown to effectively interfere with natural 
miRNA expressions (Lennox & Behlke, 2011; Baumann & Winkler, 2014). 
In the context of PD, the impact of infection-induced miRNA expressions with 
common periodontal pathogens, like Pg, has been evaluated mostly on gingival tissue samples. 
Several miRNAs which are differentially expressed between healthy and diseased tissues have 
been identified (Stoecklin-Wasmer et al., 2012). However, a precise correlation between 
specific pathogens and the different cell types involved in periodontal tissue destruction has 
not been made. 
1.2. Bone Regeneration 
One of the most significant clinical manifestation of PD is bone loss due to 
inflammation (Grossi et al., 1995; Baker, 2000; Cochran, 2008). Inflammatory mediators such 
as IL-1, TNF-α and many others have been associated with this bone loss (Assuma et al., 1998; 
Jämsen et al., 2017). Inflammation modulations is a fundamental contributor to the bone 
regeneration (Mountziaris & Mikos, 2008; Thomas & Puleo, 2011). Bone regeneration is a 
composite, physiological process of bone formation that can be observed during fracture 
healing and other clinical scenarios. Often, a high degree of bone regeneration is required in 
the reconstruction of large bone defects such as those due to infection, tumor resection, and 
skeletal abnormalities. In some cases, bone formation can be compromised via avascular 
necrosis, atrophic non-unions and osteoporosis. In most of these situations, bone induction is 
necessary to allow for a desirable healing process, There are currently many different strategies 
to augment the impaired or 'insufficient' bone-regeneration process, including the 'gold 
standard' autologous bone graft, allograft implantation, and use of growth factors (Dimitriou 
et al., 2005).  
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Clinically, any bone defect that does not heal completely without intervention is 
defined as being a Critical Size Defect (CSD) (Spicer et al., 2012). This concept has been 
created in animal models to evaluate alternative regimens to adjunct bone regeneration process 
(Cowan et al., 2004; Spicer et al., 2012; Cordova et al., 2014). The mouse model is widely 
accepted for bone regeneration studies (Cowan et al., 2004). Many researchers report 3-4mm 
circular calvaria bone defects as being a CSD (Cordova et al., 2014). 
1.3. Material with osteogenic potentials 
Poly-N-acetyl glucosamine (PGIcNAc) is a chemical compound that is extracted from 
microalgae (Maus, 2012). It is commercially available as a thin 5x5 cm white sheet that is FDA 
approved for the treatment of impaired skin lesions such as venus leg ulcers. 
Platelet-Rich-Plasma (PRP) is source of platelet-derived growth factor that has been 
advocated as an adjunct to bone regeneration (Marx et al., 1998). PRP can easily be prepared 
by sequestering and concentrating platelets via gradient density centrifugation. This technique 
produces a sufficient concentration to induce bone formation (Marx et al., 1998). It is reported 
that PRP-thrombocyte increases bone formation in the dento-alveolar region (Weibrich et al., 
2002). Other studies also show evidence that PRP can induce skin healing and reduces scar 
formation at graft-donor sites (Marx, 2004). A recent study by Joshi Jubert et al. asserts that 
single intra-articular PRP-injection can improve daily activities and reduce pain in late stage 
osteoarthritis patients (Joshi Jubert et al., 2017). 
Leukocyte-Rich-Platelets-Fibrin (L-PRF), a widely used product in dental surgery, has 
been described as a second generation PRP product. The main difference between PRP and L-
PRF is the lack of anti-coagulant use during preparation, thus allowing for clot formation 
during L-PRF preparations (Dohan et al., 2006; Di Lauro et al., 2015). Research has indicated 
that L-PRF, similar to PRP, improves epithelial tissue healing and enhances tissue growth in 
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the dental region (Dohan et al., 2006; Di Lauro et al., 2015). Kim et al. demonstrated that L-
PRF can reduce inflammation and induces osteoblast differentiation of dental pulp cells 
exposed to lipopolysaccharide (Kim et al., 2017). In a human study, Varghese et al. notes better 
osseous formation and faster healing associated with L-PRF use (Varghese et al., 2017). 
Bone Morphogenic Protein 2 (BMP2) is an FDA approved drug for bone regeneration 
in humans. BMP2 is a member of the TGF-β superfamily, a group of proteins known to 
enhance bone growth (Hoodless et al., 1996). Zara et al. reported, in a rat study, that BMP2 
not only produces bone, but also can induce irregular bone formation at high doses with 
undesirable soft tissue swellings (Zara et al., 2011). It is also well documented that activation 
of the BMP2 gene in skeletal muscles is a strong activator for ectopic bone formation (Kawai 
et al., 2003). Furthermore, applying low doses of BMP2 at any site using collagen sponge was 
found to be sufficient to produce ectopic bone (Tachi et al., 2011). More importantly, BMP2 
is a cancer promoting factor at high does; it has been shown to promote cell invasion in oral 
squamous cell carcinoma (Kim et al., 2014). 
2. Aims of the Study 
The aim of this study was to identify miRNAs differentially expressed by macrophages 
in response to Pg infection and to assess their impact at the cytokine level. Furthermore, we 
wanted to evaluate, in vitro and in vivo, the ability of miRNAs with anti-inflammatory 
properties to reduce inflammatory effects associated with Pg infection. Secondly, this study 
aimed to find a reliable alternative to BMP2 for bone regeneration in CSD. The study utilized 
a mouse calvaria model because it provides a highly controlled environment for bone 
formations. The tested materials were collagen Sponge (SurgiFoam), PRP, L-PRF, and 
PGIcNAc.   
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AIM I: MODULATION OF INFLAMMATION 
3. MATERIALS AND METHODS 
3.1. Bacterial strain 
The Pg (ATCC 33277) (kindly provided by Dr R. Lamont, University of Louisville, 
KY, USA) was cultured and maintained on enriched trypto-soy agar plates containing a 
mixture of defibrinated sheep blood, 5 mg/ml hemin, and 1 mg/ml menadione, at 37°C in 
anaerobic conditions. Then, bacterial colonies were transferred into a Brain Heart Infusion 
medium (Becton, Dickinson and Company, Sparks, MD, USA) supplemented with the hemin 
and menadoine as indicated previously. On the day of infection, bacteria were centrifuged, 
washed with PBS and the number of bacteria was determined by measuring the optical density 
at 600nm. 
3.2. Macrophage cultures 
Bone-marrow-derived macrophages (BMMs) were harvested as described in a previous 
study (Zhang et al., 2008). Briefly, bone marrow cells from femora of donor mice were 
incubated for 7 d at 37°C in a RPMI medium supplemented with L929. BMMs were cultured 
in a RPMI medium supplemented with 100,000 U/l of penicillin, 100 mg/l of streptomycin and 
10% of FBS in a humidified atmosphere with 5% CO2. 
3.3. Infection of BMMs with Pg  
1x106 BMMs were plated in 6-well plates. Adherent BMMs were infected with live Pg 
at a multiplicity of infection of 25 (Zhou et al., 2007). Cells and supernatants were harvested 
3 h after infection with live bacteria.  
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3.4. RNA extraction and microarray analysis 
BMMs were washed with cold PBS 3h after infection and the total RNAs were 
extracted using a miRNeasy Mini Kit (Qiagen, Valencia, CA, USA) according to the 
manufacturer’s instructions. Collected RNA was verified using RNA 6000 Nano Assay RNA 
chips run in an Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA). The 
RNAs, a total of 300μg from each sample, were then labeled with a FlashTag HSR Kit 
(Genisphere Inc., Hatfield, PA, USA) according to the manufacturer’s protocol. The labeled 
RNAs were hybridized with the miRNA 4.0 arrays (Affymetrix, Santa Clara, CA, USA) for 
16h in the GeneChip Hybridization Oven 640 at 48oC with rotation (60 rpm). The hybridized 
samples were washed and stained using the Affymetrix Fluidics Station 450. The first stain 
with streptavidin-R-phycoerythrin was followed by signal amplification using a biotinilated 
goat anti-streptavidin antibody and another streptavidin-R-phycoerythrin staining 
(Hybridization, Washing and Staining Kit, Affymetrix, Santa Clara, CA, USA). Microarrays 
were immediately scanned using the Affymetrix GeneArray Scanner 3000 7G Plus 
(Affymetrix, Santa Clara, CA, USA). The Affymetrix Expression console software was used 
for summarization, normalization and quality control of the resulting CEL files. All 
experiments were performed in triplicate. 
3.5. Data processing 
Raw Affymetrix CEL files (GeneChip miRNA version 4.0 array) were normalized to 
produce probeset-level expression values for all mouse and control probesets using the 
Affymetrix Expression Console (version 1.4.1), Robust Multiarray Average (Irizarry et al., 
2003) and Detection Above BackGround Analysis was limited to 1,908 mature mouse 
miRNAs assessed by the array. A Principal Component Analysis was performed using the 
'prcomp' R function with expression values that had been normalized across all samples to a 
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mean of zero and a standard deviation of one. Analyses of variance were performed using the 
'f.pvalue' function in the sva package (version 3.4.0). Pairwise differential miRNA expression 
was assessed using the moderated (empirical Bayesian) t-test implemented in the limma 
package (version 3.14.4) (i.e., creating simple linear models with lmFit, followed by empirical 
Bayesian adjustments with eBayes). Correction for multiple hypotheses testing was 
accomplished using the Benjamini-Hochberg false discovery rate (Benjamini & Hochberg, 
1995). All statistical analyses were performed using the R environment for statistical 
computing (version 2.15.1). 
3.6. Identification and analysis of predicted target genes of differentially 
expressed miRNAs  
MiRWalk 2.0 (http://www.umm.uni-heidelberg.de/apps/zmf/mirwalk/) (Dweep et al., 
2014) was used to identify putative target genes from 8 identified miRNA with a predicted  p-
value <0.05. Interactomics data were extracted from the STRING 10 database (Szklarczyk et 
al., 2015), which contains known and predicted physical and functional protein-protein 
interactions (PPI) from diverse sources. Only interactions with the highest confidence were 
selected (combined score >= 0.9). The open source software platform Cytoscape 3.2.1 
(Shannon et al., 2003)  was used to visualize and analyze PPI networks. The clusterMaker2 
0.9.5 plugin (Morris et al., 2011) from Cytoscape and in particular, the Markov Clustering 
algorithm (MCL) (Enright et al., 2002) (granularity parameter = 2.5) was applied to identify 
topological modules. KEGG pathway enrichment analysis was performed with DAVID release 
6.8 (Huang et al., 2008), in order to study the functional significance of the modules. 
3.7. Transient miRNA transfections 
 The miScript miRNA mimics used were syn-mmu-miR-155-5p (miR-155), syn-mmu-
miR-2137 (miR-2137), syn-mmu-miR-7674-5p (miR-7674) and syn-mmu-miR-8109 (miR-
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8109) and the miScript miRNA inhibitors used were anti-mmu-miR-155-5p (anti-miR-155), 
anti-mmu-miR-2137 (anti-miR-2137), anti-mmu-miR-7674 (anti-miR-7674), anti-mmu-miR-
8109 (anti-miR-8109). All were purchased from Qiagen (Valencia, CA, USA). For control, 
AllStar Neg. siRNA AF 546 was used (Qiagen). One day prior to the transfection, 4x105 cells 
were seeded in a 24-well plate. Transfection was performed using a HiPerfect Transfection 
Reagent (Qiagen), according to the manufacturer’s protocol. BMMs were transfected with 
miRNA mimics or inhibitors at a final concentration of 50 nM and infected with Pg (MOI=25). 
3.8. Cytokine analysis 
The supernatants of the Pg-infected BMMs that were transfected with the miRNA 
mimics or inhibitors were collected after 24 h of treatment. The levels of TNF-α and IL-10 
(Life Technologies Corporation, Carlsbad, CA USA) were evaluated using ELISA kits 
according to the manufacturer’s protocol. 
3.9. Calvarial bone resorption mouse model 
 The 8 to 12 weeks-old wild-type C57BL/6J mice used in this study were purchased 
from The Jackson Laboratories (600 Main Street, Bar Harbor, ME, USA). All experiments 
involving animals were approved by the Boston University Institutional Animal Care and Use 
Committee and were performed in compliance with relevant animal care and use laws. Regular 
mice chow and water were provided ad libitum. The mice (n=4) were separated into the 
following four groups: (I) Pg-infected mice as the control; (II) Pg and 8μg miR-155 and 8μg 
anti-miR-2137 inhibitor (herein, this group is referred to as combination group); (III) Pg and 
16μg miR-155; and (IV) Pg and 16μg anti-miR-2137. The final volume of each individual 
injection was 100μl in PBS. 
All of the procedures were done under anesthesia as previously described (Graves et 
al., 2005). Anesthesia was obtained after an intraperitoneal injection of ketamine-xylazine. 
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First, the heads of mice were shaved, then subcutaneous injections of Pg (5x108 CFU in 100 
μl of PBS) along with either the mmu-miR 155 mimic, or mmu-miR 2137 inhibitor, or both 
were injected at the same site. Injections were carried out with a 30.5-gauge needle at a point 
on the midline of the skull between the ears and eyes. Mice were sacrificed 7 days after the 
injection. The size of the lesion resulting from injection in each animal (area in mm2) was 
analyzed using ImageJ. 
3.10. Histological analysis  
The calvarium of each mouse was fixed in 2% paraformaldehyde in PBS (Affymetrix, 
Inc. Cleveland. OH, USA) for 2h at room temperature and refrigerated in PBS until further 
processing. Samples were embedded in an optimum-cutting-temperature-compound (Fisher 
HealthCare, Houston, TX, USA), frozen and then sectioned. Sections of 5-8µm were stained 
with hematoxylin and eosin (H&E) and prepared for further analysis. To analyze osteoclast 
activity, a Tartrate-resistant acid phosphatase (TRAP) assay was performed according to an 
already established protocol (Chiang et al., 1999). To quantify the histological sections, 
samples were evaluated by double blinded examiners according to three different scoring 
protocols: a) calvarial bone resorption was assessed using a scoring of 0 through 4 with 0: 
corresponding to no calvarial bone resorption, 1:  ¼ of calvarial bone was affected but no 
through and through penetration; 2: ½ of calvarial bone was affected but no through and 
through penetration, 3: half of calvarial bone with through and through bone penetration less 
than 1mm in width;  4: more than ½ of the calvarial bone was affected with through and through 
bone penetration greater than 1mm;  b) osteoclast activity was assessed using a score of 0 
through 3, 0: corresponding to no osteoclast with no sign of bone resorption; 1:  presence of 
some osteoclasts lacunae with minimal bone resorption; 2: presence of 5-10 osteoclast lacunae 
with bone resorption  and 3:  presence of more than 10 osteoclasts with lacunae and severe 
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bone resorption; c) inflammatory cell infiltration (ICI) was assessed using a scoring of 0 
through 5; 0: corresponding to no sign of inflammation; 1: incipient  inflammatory cells 
infiltration (ICI) in derma/subderma; 2: mild ICI in derma/subderma; 3: moderate ICI in 
derma/subderma and scarce inflammation in bone surroundings, 4 advanced ICI in derma, 
subderma and mild inflammation in bone surroundings, and 5: severe ICI in derma, subderma 
and advanced inflammation in bone surroundings. 
3.11. Statistical analysis 
Data were analyzed for statistical significance using XLStat (Addinsoft, New York, 
USA). P-values were calculated using the Mann-Whitney’s t-test.  
  
 12 
4. RESULTS 
4.1. Differentially expressed miRNAs between control and infected cells 
To evaluate the effects induced by Pg infection on the miRNAs expression profile in 
BMMs, the expression profile of 1,908 mouse miRNAs was analyzed by a microarray analysis. 
203 miRNAs showed a differential expression with a false discovery rate, corrected p-values 
(q) at <0.25, and clustering trends appeared between the groups (Figure 1). The analysis was 
restricted to the most differentially expressed miRNAs identified with higher stringency 
parameters (a threshold of fold-change (≥ or ≤ 2), p and q (≤0.001) values). Therefore, eight 
miRNAs were differentially expressed between BMMs and the Pg-infected BMMs. Five 
miRNAs were up-regulated (mmu-miR-7674-5p, mmu-miR-6975-5p, mmu-miR-155-5p, 
mmu-miR-347-3b, mmu-miR-347-3e) and 3 were down-regulated (mmu-miR-2137, mmu-
miR-8109, mmu-miR-211-3p) (Table 1). The results obtained with the microarray analysis 
were validated by RT-qPCR for all the identified miRNA except for mmu-miR-6975-5p and 
mmu-miR-8109 due to primer GC content and technical issues (Table 1). 
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miRNA differentially expressed upon P. gingivalis infected Macrophages 
Up-regulated                                                                                                      Fold change 
mmu-miR-7674-5p                                                                                    (27.3) 
mmu-miR-6975-5p                                                                                    (4.4) 
mmu-miR-3473b                                                                                       (2.7) 
mmu-miR-3473e                                                                                        (2.7) 
mmu-miR-155-5p                                                                                      (5.4) 
 
Down-regulated 
mmu-miR-8109                                                                                          (-3.3) 
mmu-miR-2137                                                                                          (-3.2) 
       mmu-miR-211-3p                                                                                       (-2.4) 
Table 1 Differential Expression of miRNA between Bone Marrow Macrophages infected with 
P. gingivalis and control (uninfected)   
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4.2. Predicting the targets of differentially expressed miRNAs 
To assist in the selection of miRNAs with potential impact on host-response and 
identify the biological pathways that may be affected by these miRNAs, a bioinformatics 
analysis was performed. Therefore, after having analyzed the putative mRNA targets of the 
differentially expressed miRNAs between naïve BMMs and Pg-infected BMMs, 3796 
Figure 1 Heatmap of differentially expressed miRNA of all of the conditioned tested. 
Red and Blue indicate z-score of ≥2 or ≤ -2, respectively, and white indicate z-score of 
zero (row-wise mean), p and q < 0.25. Experiment performed in triplicate. 
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potential target genes were predicted. The number of predicted target genes varied from 44 
(mmu-miR-8109) to 1262 (mmu-miR-6975-5p). Interactions of target genes were extracted 
from the STRING database and the resulting protein-protein interaction (PPI) network was 
visualized using Cytoscape. To facilitate analysis, only proteins with at least two interactions 
with identified targets were considered. The network contains 6746 nodes and 51470 edges, 
where nodes represent target genes and edges represent interactions between target genes. 
Topological modules (densely connected regions) were identified by the MCL clustering 
algorithm. 639 modules were identified, among which 211 modules contained more than 5 
nodes and the largest module contained 613 nodes. Pathway analysis led to the identification 
of miRNAs target genes in several pathways related to the inflammatory response including 
chemokine signalling pathway and cytokine-cytokine receptor interaction (Table 2). 
Interestingly, even though several pathways related to cell’s life were identified, such as cell 
cycle, ribosome, spliceosome, from the 10th largest identified topological modules, 3 of them 
were linked to pathways related to the inflammatory response highlighting the potential 
involvement of identified miRNAs on the modulation of inflammatory response in BMMs Pg 
infected. 
 
  
 16 
Topological module and predicted 
pathways 
Benjamini-corrected P value 
 
Olfactory transduction                                              0.0E0 
Neuroactive ligand-receptor interaction                      1.2E-107 
Taste transduction                                         4.9E-36 
Calcium signaling pathway                                 1.5E-19 
Chemokine signaling pathway                              2.7E-17 
Cytokine-cytokine receptor interaction                       4.3E-8 
Complement and coagulation cascades                       5.7E-6 
CyclicAMP signaling pathway                              6.6E-6 
Ribosome                                                 1.2E-141 
Protein export                                             1.3E-19 
Cell cycle                                                 3.0E-86 
Progesterone-mediated oocyte maturation                   1.7E-25 
Oocyte meiosis                                             1.7E-24 
HTLV-I infection                                          1.8E-13 
p53 signaling pathway                                      6.8E-12 
Viral carcinogenesis                                        20.7E-11 
Ubiquitin-mediated proteolysis                              8.7E-11 
Small-cell lung cancer                                      2.3E-9 
Hepatitis B                                                1.2E-8 
FoxO signaling pathway                                    3.5E-8 
Pathways in cancer                                         2.3E-7 
PPAR signaling pathway                                   2.4E-21 
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Thyroid hormone signaling pathway                          1.2E-19 
Adipocytokine signaling pathway                            3.6E-7 
Bile secretion                                                          4.3E-5 
Table 2 Predicted pathways of the identified target genes of 155-5p miRNAs. The predicted 
pathways of the largest topological modules are presented. Only pathways with a Benjamini-
corrected p value of < 0.00001 were considered. Boldface type indicates pathways related to 
immune and inflammatory response. 
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4.3. Impact of identified miRNAs on TNF-α and IL-10 secretion in BMMs 
 To evaluate the effect of identified miRNAs on the inflammatory response, BMMs 
were transfected with mimics and inhibitors of the most differentially expressed miRNAs 
(mmu-miR-155-5p, mmu-miR-2137, mmu-miR-7674, mmu-miR-8109). This experiment 
aimed at evaluating the specific effect of each miRNA to assess their role on the inflammatory 
response to Pg infection and especially on pro-inflammatory TNF-α and anti-inflammatory 
IL-10 secretion. 
Transfection of BMMs with miR-155 and miR-2137 did not modify significantly TNF-
α secretion. Their respective inhibitors, on the other hand, increased significantly its secretion 
level. Regarding miR-7674 and miR-8109, transfection induced an increase of TNF-α to a 
lesser extent than transfection with their respective inhibitors (Figure 2A and Table 3). 
Regarding IL-10 secretion, only a few of the tested miRNAs modified its secretion profile 
significantly. Mimic of mmu-miR-7674 and inhibitors of mmu-miR-2137 and mmu-miR-8109 
induced a significant increase of IL-10 release in comparison with control (p<0.05) (Figure 2B 
and Table 3). However, even though statistical significance was reached, the increase was 
small. Therefore, it appears that some of the identified miRNAs and inhibitors are able to 
modulate the secretion rate of these two cytokines. 
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Figure 2 (A) TNF-α secretion in transfected BMMs with selected miRNAs and their inhibitors 
(*, p<0.05). (B) IL-10 secretion in transfected BMMs with selected miRNAs and their 
inhibitors (*, p < 0.05). 
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4.4. BMMs transfection with selected miRNAs modulates cytokines secretion 
induced by Pg infection 
To evaluate if a concomitant exposure to selected miRNAs is able to modulate cell’s 
response to Pg infection, transfected BMMs were infected and TNF-α/IL-10 secretion were 
evaluated. Interestingly, transfection with miR-155 significantly decreased TNF-α secretion 
by 30% (Figure 3A and Table 3). In contrast, this effect was not observed for other mimics or 
inhibitors. Regarding IL-10 secretion, the transfection of anti-miR-2137 increased 
significantly IL-10 secretion (Figure 3B and Table 3) while miR-155 and anti-miR-7674 
decreased it significantly (p<0.05).  
Taken together, these data showed that the transfection with miRNAs especially miR-
155 or anti-miR-2137 modulates the host-response to Pg infection.  
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Figure 3 (A) Dosages of TNF-α in supernatants of transfected BMMs infected with P. 
gingivalis (Pg) at 24h. *, p< 0.05 versus P. gingivalis plus scramble. (B) Dosages of IL-10 in 
supernatants of transfected BMMs infected with P. gingivalis at 24h. *, p< 0.05 versus P. 
gingivalis plus scramble. 
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Table 3 the effect of over expression or inhibition of selected miRNA on the levels of IL-10 
and TNF-α at the presence or absence of Pg infection to BBMs. When (+) denotes 
statistically significant increase, (-) denotes statistically significant decrease, and (none) 
indicates no statistical significant change. 
 
 
 
 
 
  
 
miRNA effect with no Pg miRNA effect with presence of Pg 
miRNA IL-10 TNF-α IL-10 TNF-α 
Scramble none none none none 
155 none none (+) (-) 
Anti- 155 none (+) none none 
2137 none none none none 
Anti-2137 (+) (+) (+) none 
7674 (+) (+) none none 
Anti-7674 none (+) (+) none 
8109 none (+) none none 
Anti-8109 (+) (+) none none 
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4.5. Effects of miR-155 and anti-miR-2137 in vivo 
 In this context, an in vivo proof of concept experiment was conducted to assess the 
potential effects of miR-155 and anti-miR-2137 in a calvarial bone resorption mouse model 
induced by Pg infection. To determine their potential role on the inflammatory response and 
bone resorption, selected miRNAs were injected concomitantly with Pg in mice calvaria. After 
7 days, the area of the induced lesion was measured for each mouse (Figure 4A), having a 
mean area of 11.08 mm2 (+/- 1.47). The injection of miR-155 alone or anti-miR-2137 alone 
concomitantly to Pg injection significantly decreased the size of the lesion (7.55 mm2 (+/-1.6) 
and 6.42 mm2 (+/-1.4) respectively), in vivo. 
Histological examinations showed some degree of ICI (leukocytes, lymphocytes and 
macrophages) in all groups (Figure 5) in comparison with untreated mice (Figure 6). However, 
animals infected with Pg and treated with anti-miR-2137 showed a reduced amount of 
inflammation (Figure 5 G-H), in comparison with Pg-infected group (Figure 5A and 5B) 
supported by quantitative analysis (Figure 4B). Regarding bone resorption, Pg infection 
induced bone resorption (Figure 4C) which correlated with an increased osteoclast activity as 
evidenced by resorption lacunae. When anti-miR-2137 was injected concomitantly to the 
infection, a significant reduction of calvarial bone loss and osteoclast activity were observed 
(Figures 4C and 4D), while mice injected with miR-155 did not show significantly reduction 
in ICI, bone loss, or osteoclast activity. However, regarding the combination group, while no 
significant reduction in ICI was observed, a trend for reduction of bone loss and osteoclast 
activity could be observed (Figures 4C and 4D). 
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Figure 4 (A) Sizes of calvarial lesions 7 days after P. gingivalis (Pg; 5 x 108 CFU) infection 
and the injection of miR-155 and anti-miR-2137. *, p< 0.05, n=4  
(B) Quantitative analysis of the index of ICI in each of the following groups: P. gingivalis-
only infected, combination group (P. gingivalis and 8µg of anti-miR-2137 plus 8µg of miR-
155), P. gingivalis and 8µg of anti-miR-2137, and P. gingivalis and 8µg of miR-155. *, p< 
0.05.  
(C) Quantitative analysis of calvarial bone resorption in each of the following groups: P. 
gingivalis-only infected, combination group (P. gingivalis and 8µg of anti-miR-2137 plus 8µg 
of miR-155), P. gingivalis and 8µg of anti-miR-2137, and P. gingivalis and 8µg of miR-155. 
*, p< 0.05.  
(D) Quantitative analysis of osteoclast activity in each of the following groups: P. gingivalis-
only infected, combination group (P. gingivalis and 8µg of anti-miR-2137 plus 8µg of miR-
155), P. gingivalis and 8µg of anti-miR-2137, and P. gingivalis and 8µg of miR-155. *, p< 
0.05. 
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Figure 5 Histological sections. Shown are representative samples of skin and underlying 
calvarial bone at the middle of the lesion from each of the following groups: P. gingivalis (Pg) 
(A to C), combination (P. gingivalis and miR-155 plus anti-miR-2137) (D to F), P. gingivalis 
and anti-miR-2137 (G to I), and P. gingivalis and miR-155 (L to N). TRAP staining of bone 
(bottom row, x200 magnification) and hematoxylin-and-eosin staining of skin (top row, x100 
magnification; middle row, x200 magnification) are shown. Arrows indicate TRAP-stained 
multinucleated osteoclasts attached to bone and bone resorption lacunae. 
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Figure 6 Representative samples for skin (A-B) & underlying calvarial bone (C) at the middle 
of the calvaria in an uninfected mouse. TRAP staining for bone (bottom row, 200x) and H&E 
staining for the skin (Top row, 100x; middle row, 200x). 
 
 
A 
B 
C 
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4.6. Identification of potential pathways targeted by mmu-miR-155 and mmu-
miR-2137 
 As some biological effects have been observed in vitro and in vivo, a new set of 
bioinformatics analysis regarding mmu-miR-155 or mmu-miR-2137 was been performed to 
determine which molecular pathway could be linked to the observed results.  
Regarding mmu-miR-155, 130 topological modules were identified by the MCL clustering 
algorithm, amongst which 52 modules contained more than 5 nodes. When the largest 
topological modules (Figure 7) were considered, several pathways related to the inflammatory 
response but also pathogen recognition were identified as potential targets including cytokines 
and chemokines related pathways, the Toll-like receptor signalling pathway and also osteoclast 
differentiation pathways. Furthermore, gene ontology analysis confirmed a potential 
involvement of this miRNAs on the genes associated with the inflammatory response 
(Benjamini corrected p-value =1.3E-24). Interestingly, one other topological module (Figure 
8) was related to the Jak-STAT pathway, a well-described pathway related to apoptosis but 
also to pro-inflammatory cytokines production notably through the targeting of TNF and NF-
kappa B signalling pathways. Furthermore, associations with pathways related to epithelial 
cells invasion and osteoclasts differentiation have also been underlined for this module 
especially through the direct targeting of PI3k-AKT pathway. 
Regarding mmu-miR-2137, 10 topological modules were identified among which 4 
modules contained more than 5 nodes. The largest module was associated with the cell cycle 
(Benjamini corrected p-value = 2.1E-12). However, no pathway related to inflammation for 
mmu-miRNA-2137 has been identified yet, even though our study showed the clear effect on 
IL-10 production.  
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Figure 7 Representative topological modules related to mmu-miR-155 target genes and 
identified pathways associated to innate immune response. In red, genes identified as directly 
affected by mmumiR-155. 
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Figure 8 Topological module related to mmu-miR-155 target genes and identified pathways 
associated to innate immune response. In red, genes identified as directly affected by mmu-
miR-155. 
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AIM II: BONE REGENRATION 
5. MATERIALS AND METHODS 
 
5.1. Mice  
One-hundred-thirty-eight pathogen-free male C57BL/6J twelve weeks old mice 
purchased form Jackson Laboratory (10 Discovery Dr, Farmington, CT 06032) were used in 
this study. Mice were fed sterile food and distilled water ad libitum and were randomly 
assigned into group of six (n=6 per group) in one of the following twenty-three experimental 
groups: 
1.  Negative control 
2. Poly-N-Acytel-glucosamine (PGIcNAc) sheets only (TM out) 
3. Crushed PGIcNAc (cTM) 
4. Crushed PGIcNAc and PGIcNAc sheet outside (cTM+TM out) 
5. Crushed Bone (cBone) 
6. Crushed Bone and crushed PGIcNAc (cBone+cTM) 
7. Crushed Bone and crushed PGIcNAc and PGIcNAc sheet (cBone+cTM+TM out) 
8. PGIcNAc gel only (TMgel) 
9. PGIcNAc gel and PGIcNAc sheet (TMgel+ TM out) 
10. Low concentration of BMP2 (0.3 µg per animal) and SurgiFoam (lBMP2+SurgiFoam) 
11. Low concentration of BMP2 (0.3 µg per animal) and SurgiFoam and PGIcNAc sheet 
(lBMP2+SurgiFoam+TM out) 
12. PGIcNAc gel and SurgiFoam (TMgel+SurgiFoam) 
13. SurgiFoam only (SurgiFrom) 
14. High concentration of BMP2(1.4 µg per animal) and SurgiFoam (1.4 µg per animal) 
(hBMP2+SurgiFrom) 
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15. High concentration of BMP2 (1.4 µg per animal) and SurgiFoam and PGIcNAc sheet 
(hBMP2+SurgiFoam+TM out) 
16. High concentration BMP2 and SurgiFoam and PGIcNAc gel 
(hBMP2+TMgel+SurgiFoam) 
17. High concentration BMP2 and PGIcNAc gel and PGIcNAc sheet 
(hBMP2+TMgel+TM out) 
18. Platelets-Rich-Plasma only (PRP) 
19. Platelets-Rich-Plasma and PGIcNAc gel (PRP+TMgel) 
20. Platelets-Rich-Plasma and PGIcNAc gel and PGIcNAc sheet (PRP+TMgel+TM out) 
21. Leukocyte-Rich-Platelets-Fibrin only (L-PRF) 
22. Leuckocytes-Rich-Platelets-Fibrin and PGIcNAc gel (L-PRF+TMgel) 
23. Leucocytes-Rich-Platelets-Fibrin and PGIcNAc gel and PGIcNAc sheet (L-
PRF+TMgel+TM out) 
The animals were allowed to heal for 6 weeks. After that, they were sacrificed and calvaria samples 
were collected and processed. 
5.2.  Poly-N-acetyl glucosamine (PGIcNAc) 
 The Poly-N-acetyl glucosamine preparation was supplied by Marine Polymer 
Technologies, Inc., Danvers, MA 01923 in two forms: 5x5cm sheets, and gels. During 
surgeries, groups denoted with TM out received 7x7mm of PGIcNAc sheet to cover the entire 
outer surface of the 5mm defect completely. 
Groups indicated to have TM gel received 14µL of the PGIcNAc gel preparation. The 
concentration of the supplied gel was 20mg/mL. The gel was placed inside the 5mm circular 
defect in the middle of the mouse calvaria. 
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Groups that received crushed PGIcNAc (cTM) were treated, in fact, with crushed 
PGIcNAc sheet. The PGIcNAc sheet of 5x5cm was manually crushed using a mortar and pestle 
until a powder form was obtained. Then enough powder to full the 5mm circular defect was 
used in each animal treated with cTM. 
5.3. Crushed Bone (cBone) 
 Homologous calvaria bone were collected from C57BL/6J mice and crushed into a 
sterile mortar and pestle manually. Bone powder was filled into the entire 5mm defect for 
groups scheduled to receive cBone.  
5.4. Reagents and recombinant Bone Morphogenic Protein 2 (BMP2) 
 Recombinant Bone Morphogenic Protein 2 (BMP2) utilized in this study was 
purchased form R&D system Catalogue# 355-BM-10 (R&D Systems, Inc. 614 McKinley 
Place NE, Minneapolis, MN 55413). Either a low amount (0.3µg) or high amount (1.4µg) of 
BMP2 per animal were used as indicated in the groups. 
Homologous Platelet-Rich-Plasma of C57BL/6J mice was prepared in 
BioreclamationIVT (123 Frost St, Westbury, NY 11590) and used fresh, within 72h of 
preparation. Each animal treated with PRP received a PRP gel that was prepared at the time of 
surgery. The PRP gel contains 25µL of fresh PRP and 5µL of mouse alpha-thrombin (Cat 
#MCT-5020, Haematologic Technologies, Inc., VT, USA). The combination of PRP-throbmin 
was allowed to form a jel for 10 minutes before insertion into the 5mm defect of the mouse 
calvaria. 
Homologous Leukocytes-Rich-Platelets-Fibrin (Munoz et al., 2016) (L-PRF) was 
prepared at the BioreclamationIVT facility and used within 72h of preparation. A 7x7mm 
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section of the L-PRF was placed over the 5mm defect with an addition of 5µL of mouse 
thrombin per animal.  
5.5. Surgical Procedure 
 Each animal was first weighed and an analgesic (i.p. Buprenorphine at dose range of 
0.05-0.1 mg/kg) was injected 30 minutes prior to the procedure. General anesthesia was 
obtained via a 50-100mg/kg Ketamine + 10-15mg/kg Xylazine by i.p. injection. Once the 
animal was fully anesthetized, the hair covering the area of interest was shaved using an 
electrical hair clipper. The surgical site was prepared and disinfected as indicated in the BU 
IACUC protocol #15544. Using surgical grade Betadine (Purdue Pharma L.P., Stamford, CT 
06901-3431), the incision site was wiped three times and allowed to completely dry. A 15mm 
incision was created at the middle of the mouse-calvaria using surgical blade size 15c 
(ThermoFisher Scientific, Inc., MA). A full thickness of skin-muscle-periosteum flap was 
raised to allow space for the drilling process. A 5mm bi-cortical bone defect was created using 
surgical trephine (Trephines for Micro Drill, catalogue#18004-50, Fine Science Tools, Inc., 
Foster City, CA 94404-1139) attached to surgical handpiece under copious irrigation. Bleeding 
was controlled using surgical gauze and manual pressure for 10 seconds. Subsequently, the 
materials of interest were inserted in the defect as indicated in each group. Figure 9 illustrates 
the procedure. 
The incision was then closed using a single interrupted suturing technique using 
resorbable suture (ACE 5-0 Plain Gut Sutures, DSM13, 18", ACE Surgical Supply Co., Inc., 
Brockton, MA). Animals were kept warm during the entire procedure and until they were fully 
awake and able to walk. Postsurgical analgesic i.p. Buprenorphine injections was administered 
at 12-hours intervals for 3 days and animals were monitored daily for 6 weeks. 
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Figure 9 Illustration of the surgical procedure steps 
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5.6.Specimen Preparation.  
Mice were sacrificed at 6 weeks and the calvarium of each mouse was harvested and 
fixed in 2% Paraformaldehyde in PBS (Affymetrix, Inc. Cleveland. OH, USA) for 2hrs. at 
room temperature and refrigerated in PBS until ready for further processing. Samples were 
embedded in an O.C.T. compound (Fisher HealthCare, Houston, TX, USA) and frozen at the 
time of sectioning. Sections of 5-8 µm were stained with hematoxylin and eosin and prepared 
for further analysis. Sections were collected at the middle of the 5mm defect as shown in Figure 
10. 
 
Figure 10 illustrate the place where histological sections collected form each mouse calvaria 
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5.7.H&E Staining protocol and Histological analysis  
 The following H&E staining protocol was followed to stain the prepared frozen 
samples for histological examinations. H&E sections were first allowed to thaw at room temperature 
for 30 minutes. Slides were then rehydrated in 1x PBS solution for 1 minute. Then slides were covered 
for 10 seconds with few drops of Fisher Chemical™ Harris Modified Method Hematoxylin Stains 
(Fisher Chemical, 168 3rd Ave, Waltham, MA 02451) and wash three times in tab water for 10 second 
each. Quickly immersed the slides for 5 times in blueish solutions (100% Li2O3) and immediately 
check of the Hematoxylin stain under microscope. Following that immersed slide in fresh 100% ethyl 
alcohol in quick motion. The slide then stained in Eosin for 20 seconds (Eosin Y, Fisher Chemical, 168 
3rd Ave, Waltham, MA 02451) and dehydrated by quick immersion in following alcohol series: 95%, 
95%, 100%, and 100%. Finally, slides were bathed in Xylene (Fisher Scientific, Pit, IL) twice 20 
seconds each, and then cover-slipped with Permount (Fisher Scientific, Pit, IL). 
Once staining was completed, images were taken using a digital camera attached to 
light microscope in ImagePro Premier Software at 20x magnification for histological 
measurements. Each image was pre-calibrated and the measurement for the remaining 
(unclosed) defect was measured in mm as illustrated in Figure 11.  
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Figure 11: Measurement method using ImagePro 
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5.8.X-ray analysis  
 Before decalcification and after fixation, radiographs were taken for each of the 
collected samples. Using an over-bench X-ray machine and using parallel technique, ordinary 
X-ray films was taken for each sample (HyBlot CL 5x7 in., Holliston, MA). During X-ray, a 
standard 1mm metal bar was used to standardize the film magnification. 
X-ray films were transferred to a digital format using a manual camera. Each image was 
calibrated individually with using a standardized metal bar in ImagePro software. Then the 
surface area of the remaining defect was calculated utilizing the ImagePro shown in Figure 12. 
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Figure 12: Measurement and calibration bar 
5.9. Alkaline Phosphatase Activity Staining and analysis 
 An alkaline Phosphatase (ALP) activity kit was purchased from Sigma Aldrich 
(Cat#85L3R, Sigma-Aldrich, St. Louis, MO). Manufacturer recommendations were followed 
for the staining protocol. Briefly, once the components were mixed, the slides were immersed 
in the staining cocktail for 30 minutes and then washed in running water. After that, the slides 
were counterstained with Hematoxylin for 10 seconds, washed and covered using Permount 
(Fisher Chemical, Fair Lawn, NJ). 
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Stained samples were analyzed under a light microscope for ALP activity and were scored as 
follows: 
Score of 0: no visible ALP activity 
Score of 1: ALP activity around both of the defect edges. 
Score of 2: ALP activity around both edges of the defect and in the middle of the defect. 
Score of 3: Strong ALP activity around the edges and the newly formed bone is less than 1mm  
Score of 4; Strong ALP activity around the defect edges and the newly formed bone is more 
than 1mm and less than 4. 
Score of 5: Strong ALP around the defect edges and the newly formed bone is more than 4mm. 
5.10. Statistical Analysis.  
All measurements were performed in a blind fashion and double-checked at a one-week 
interval. Intra-examiner variation was found to be less than 5%. A two-tailed Student’s t-test 
was emphasized for comparison between two groups was performed. A p-value of <0.05 was 
considered to be statistically significant. 
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6. RESULTS 
6.1. X-ray Analysis 
 Our study aimed to compare the four different materials, PGIcNAc, PRP, L-PRF and 
BMP2. The unhealed areas measured in mm2 show that untreated mice (negative control) 
exhibited a 55% healing after six week. However, mice treated with high concentration of 
BMP2 displayed up to 95% closure of the 5mm defect. At low BMP2 concentration, it allowed 
for 80-85% closure. Additionally, any treatment combination that contained the BMP2 was 
sufficient to produce bone healing in CSD. This was statistically significantly higher than in 
all other treatment groups. All physical forms of PIGcNAc, sheet, crushed powder, gel or any 
combination of this material was not able to close more than 60-65% of the original CSD. This 
was not a statistically significant different when compared to the negative control. Groups that 
received PRP, L-PRF or any combination of this material did not produce a statistically 
significant difference from the negative control. Representative X-rays are depicted in Figure 
16-18 and measurements are shown in Figures 13-15. 
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Figure 13 Data represent the percentage of the defect area closed as measure on X-rays. * 
indicate significant p<0.05 
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Figure 14 Data represent the percentage of the defect area closed as measure on X-rays. * 
indicate significant p<0.05 
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Figure 15 the remaining groups. * indicate significant p<0.05 
 
30
40
50
60
70
80
90
100
%
% Area of Bone Formation measured in X-rays 
* 
 45 
 
 
 
 
 
 
Figure 16 Representative radiographs 
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Figure 17 Representative radiographs. 
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Figure 18 Representative radiographs. 
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6.2.Histological Analysis 
H&E stained slides were analyzed utilizing a light microscope attached camera in an 
ImagePro Premier program. The results show that groups treated with BMP2 were able to close 
90-95% of the original defect, which is statistically significantly higher than all other groups 
with p<0.05. These groups include BMP2 at low or high concentration loaded in SurgiFoam 
sponge. Additionally, the TMgel BMP2 and TMgel BMP2 and TM-out group showed a similar 
trend. On the other hand, groups that were treated with PRP, L-PRF, or any combination of the 
crushed or sheet TM was able to close 60% of the original 5mm CSD. These results were not 
statistically significant different from the untreated negative control group. Figures 22-29 show 
representative images from each groups and Figures 19-21 show the quantitative results.  
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Figure 19 Barograph shows the histological measured sections 
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Figure 20 Barograph shows the histological measured sections 
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Figure 21 The remaining groups 
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Figure 22 Representative Images G1-3, Top row 20x bottom 100x 
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Figure 23 representative images G4-6, Top row 20x bottom 100x 
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Figure 24 Representative Images G7-9, Top row 20x bottom 100x 
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Figure 25 Representative Images G10-12, Top row 20x bottom 100x 
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Figure 26 Representative Images G13-15, Top row 20x bottom 100x 
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Figure 27 Representative Images G16-17, Top row 20x bottom 100x 
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Figure 28 Representative Images G18-20, Top row 20x bottom 100x 
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Figure 29 Representative Images G21-23, Top row 20x bottom 100x 
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Interestingly, the histological analysis showed that the quality of the bone associated 
with the groups treated with TMgel or TM-out did allow better bone organization. 
Additionally, the TMgel was a bone-friendly material that did not by any means reduced or 
interfered with bone formation. In fact, we observed that the TMgel has been engulfed by the 
newly formed bone. Figures 28-31 depict different combinations of TMgel and TM sheet that 
demonstrate the compatibility of the materials tested with the bone tissue.  
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Figure 30 Organization of bone when TM out used versus not TM sheet. 
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Figure 31 Arrows point to the TM sheet inserted within the new bone 
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Figure 32 Arrows point to TMgel inside the newly formed bone at 4 weeks 
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Figure 33 Arrows point to TMgel inside the newly formed bone after 6 weeks 
200x 
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Figure 34 Arrows point to the TMgel inside the newly formed bone, which indicates the 
TMgel compatibility with bone and other materials 
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6.3.ALP activity Analysis  
 The results demonstrate that the BMP2 groups showed significantly higher ALP 
activity when compared to all other groups. Any combinations that did not contain BMP2 did 
not present with high ALP activity. Figures 38 and 39 show selected groups for representation 
and Figure 35-37 shows the quantitative scoring for the ALP activity. 
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Figure 35 Quantitative ALP activity score 
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Figure 36 Quantitative analysis of ALP activity p<0.001 
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Figure 37 Quantitative analysis of ALP activity p<0.001. 
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Figure 38 Selected groups showing ALP activity. The ALP levels were evaluated by the 
increase of red color intensity. 
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Figure 39 ALP activity images. The ALP levels were evaluated by the increase of red color 
intensity. 
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7. DISCUSSION 
This study was aimed at evaluating the effects of Pg infection on miRNA expression 
in BMMs and to evaluate their role on the inflammatory host-response in vitro and in vivo. 
This wide-scale analysis led to the identification of several miRNAs differentially expressed 
in infected cells. In order to determine the effects associated to this modulation and potential 
implication on innate immune response, the focus was placed on miRNAs that had high level 
of significance. Through bioinformatics prediction and the protein level of cytokines secretion 
have been conducted suggesting a role for mmu-miR-155-5p, mmu-miR-2137, mmu-miR-
7674 and mmu-miR-8109 in Pg induced host-response modulation.  Interestingly, the present 
study also showed the potential therapeutic approach of using specific miRNAs to control Pg 
induced inflammatory response in a mouse model of inflammation and bone resorption. 
The capacity for modulation of the host-response caused by Pg infection is part of the 
bacterial survival strategy. Several mechanisms have been developed by such bacteria in order 
to invade and proliferate within the host-cells, whether at the gene (Yu et al., 2010) or protein 
level (Li et al., 2014; Huck et al., 2015). Regulation of protein expression is critically important 
in homeostasis and pathology. Because miRNAs have been shown to control 30% of all 
protein-coding genes and also to participate in the regulation of almost every cellular process 
(Filipowicz et al., 2008; Simo et al., 2015), miRNAs could be considered as important post-
transcriptional regulators. Their expression has been related to the dysregulation of several 
biological processes in both innate and adaptive immune responses (Kebschull et al., 2015). 
The impact of infection on miRNA expression has already been described for several bacteria 
in different cell models. This is especially true for macrophages that play an important role in 
cytokine secretion, immune response and in early recognition and clearance of bacteria (Silva 
et al., 2015). For instance, in a model of human macrophages infected with Mycobacterium 
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tuberculosis, it has been observed that the infection leads to the specific expression of several 
miRNAs that play key roles in immune and inflammatory pathways (Zheng et al., 2015). In 
the context of PD, up or down-regulation of several miRNAs expression have also been 
observed such as miR-155, miR-200 or miR-146 that are involved in the regulation of several 
cellular processes including the control of Toll-like receptor (TLR) sensitivity, cell cycle, 
apoptosis and autophagy (Kebschull et al., 2015). More specifically, effects on miRNA 
regulation induced by keystone pathogens such as Pg have also been investigated. In 
macrophages, stimulation by Pg-lipopolysaccharide modulates the expression of miR-24, a 
negative regulator of classical macrophage activation (Fordham et al., 2015). In our model, Pg 
infection down-regulated mmu-miR-211-3p expression; this observation was also visible in an 
infection model of Candida albicans, contributing to the suppression of the host-immune 
response (Li et al., 2014). Interestingly some other miRNAs have already been described as 
potential regulator of the host-immune response induced by Pg or its virulence factors such as 
miR-146a that down-regulates pro-inflammatory cytokine secretion through blocking of TLRs 
pathways in vitro (Benakanakere et al., 2009; Jiang et al., 2015)   or in vivo (Nahid et al., 
2011). Several others pathways have been identified as putative targets for Pg leading to 
uncontrolled cytokines secretion such as SOCS3 (Moffatt & Lamont, 2011). 
In the study, the effects induced by Pg infection were evaluated on 1,908 miRNAs. We 
observed that the infection leads to the specific modulation of the expression for 8 miRNAs: 
mmu-miR-155-5p, mmu-miR-211-3p, mmu-miR-2137, mmu-miR-3473b, mmu-miR-3473e, 
mmu-miR-6975-5p, mmu-miR-7674-5p, and mmu-miR-8109.  
MiR-155 expression was up-regulated by Pg infection. This miRNA is abundantly 
expressed in immune cells, such as macrophages, active B and T cells, and in dendritic cells. 
It is involved in the immune response as well as in the protection against the harmful effects 
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of inflammation through the modulation of pathways related to apoptosis, proliferation and 
host-pathogen interaction(s) (Dickey et al., 2016). Interestingly, in human gingival tissues 
affected by PD, an increase in miR-155 expression has already been observed (Stoecklin-
Wasmer et al., 2012), with several pathogens seemingly able to increase it. In a model of 
macrophages infected with Helicobacter pylori, the increased expression of miR-155 acts as 
an inflammatory promoter, inducing pro-inflammatory cytokines secretion (TNF-α, IL-23, IL-
10, IL-8) (Yao et al., 2015). However, in our in vitro model of transfection, miR-155 did not 
modify the secretion of TNF-α while its inhibition increased TNF-α level significantly, 
demonstrating a potentially differential effect. The observed effect might be dependent on the 
type of pathogen, cell type or the methods of miRNA delivery.  
Interestingly, some bemusing results have been observed regarding the effects of miR-
7674 and 8109 and TNF-α secretion while transfection with corresponding mimics and 
inhibitors induced both an increase of this cytokine secretion. It appears difficult to explain 
such unspecific modulation as precise targets related to TNF-α are not already described for 
these miRNAs. Additional experiments are required to fill those gaps of knowledge. 
Regarding IL-10, some of the tested miRNAs displayed effects on its secretion in 
macrophages through the increase of this anti-inflammatory cytokine level. It is important to 
take into account that this observed increase of IL-10 secretion in transfected BMMs was small, 
emphasizing the need of confirmatory experiments regarding their impact on specific 
molecular pathways associated to IL-10 secretion. However, we can hypothesize that this may 
underline the potential role of these particular miRNAs on the innate immune response, since 
the down-regulation of miRNA expression by Pg-infection is a known bacterial survival 
strategy (Martin et al., 2003; Yilmaz et al., 2004). Therefore, these effects may contribute to 
the modulation of the host-response by Pg as suggested by the bioinformatics analysis. 
 75 
Since PD is a chronic disease, infection may occur in already activated cells. Accordingly, the 
effect of Pg infection has been evaluated in pre-treated macrophages. Our results showed that 
the cell response to infection is modulated by such pre-treatment. For instance, a decrease of 
TNF- α secretion was observed in cells transfected with miR-155 and infected with Pg. 
Therefore, we hypothesized that the modulation of miR-155 expression by Pg is one of the 
mechanisms developed by the bacteria to restrain host-immune response to Pg infection. An 
anti-inflammatory effect was also observed when macrophages were transfected with anti-
miR-2137 and infected with Pg resulting in an amplification of anti-inflammatory IL-10 
secretion. From a therapeutic point of view, their ability to reduce the pro-inflammatory and 
to promote anti-inflammatory aspects of the host-response may be an interesting strategy to 
control the adverse effects induced by Pg infection. 
Furthermore, our in vitro results were confirmed in vivo in a proof of concept mouse 
model. We elected to use the calvarial model for proof of concept to assess the impact of 
identified miRNAs mimics or inhibitors on the modulation of bone resorption induced by Pg 
(Graves et al., 2012). This model has often been used to study bone repair and soft tissue 
healing in response to infection and allows the delivery of a precise amount of the miRNAs to 
a proper location in the context of a monoinfection associated with Pg. At the histological 
level, Pg infection induced bone loss, as reported previously (Meka et al., 2010).  Interestingly, 
co-injection with miR-155 or anti-miR-2137 decreased significantly some aspects of the 
induced lesion, notably by reducing its size. Through their modulation of macrophage 
polarization, as for miR-155 (Essandoh et al., 2016), the therapeutic potential of miRNAs has 
already been proposed in the treatment of several inflammation-related diseases. Previously, it 
was shown that miR-155 was able to affect the expression levels of other miRNAs (Kebschull 
et al., 2015), which may explain the observed effect in vivo. Such a role was already suggested 
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for miR-155 in a previous study (Zhang et al., 2012) where this miRNA was described as 
having modulated osteoclastogenesis by targeting SOCS1 and MITF. Interestingly, our in vivo 
model showed that the reduction of TNF-α by miR-155 was not enough to significantly 
decrease ICI, bone loss or osteoclast activity. Further investigation into the role of miR-155 in 
inflammation might reveal an alternative pathway. Regarding mmu-miR-2137, in vitro results 
were substantiated in vivo when anti-miR-2137 was co-injected with Pg, leading to a reduction 
in osteoclast activity and bone loss. This indicated a potential role in bone metabolism for anti-
miR-2137 and revealed that the increase of IL-10 production caused by the miR-2137 
inhibition was sufficient to produce a robust reduction in Pg-induced inflammatory cell 
infiltrates, bone loss, or osteoclast activity. However, the injection of the combination group 
did not affect the size of the lesion associated with Pg infection as we had hypothesized. This 
may be a consequence of the ability of miR-155 to affect the expression of other miRNAs 
(Kebschull et al., 2015). This could also be attributed to the fact that we used a lower 
concentration of each miRNA, due to the inherent miRNA toxicity seen at a higher 
concentration in our in vivo model. More importantly, the quantitative histological examination 
revealed that the effect of miRNA-155 on TNF-α was not sufficient to reduce the strong 
inflammation produced by Pg, which in turn could reverse the robust effect that was produced 
by anti-miR-2137. However, osteoclast activity was significantly reduced by this combination. 
These results should be confirmed in a specific model of experimental periodontitis such as 
oral gavage or with the infected-ligature induced model (Graves et al., 2012) to evaluate 
precisely the potential therapeutic interest of these miRNAs in the context of a more complex 
lesion induced by the biofilm multispecies complex present in PD. 
Recently, the roles and functions of miRNAs have been more appreciated in the context 
of PD. However, available studies analyzed miRNA expression between healthy and diseased 
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gingival biopsies without taking the differences of cell populations into account, leading to 
biased results (Kebschull et al., 2015). To prevent skewed results due to preactivation of 
macrophage cells, our study focused on BMMs that can be considered to be naïve cell 
population. Indeed, the macrophages response to infection is certainly under the influence of 
several factors including preactivation (Papadopoulos et al., 2016) ruling out using periotoneal 
macrophages.  
Micro-RNA research in the periodontal field is a work in progress as knowledge 
increases continuously. However, the identification of new miRNA sequences calls for 
attention. In our study, some of the identified miRNAs were poorly described in the literature 
and the potential molecular pathways involved in their action could only be approached 
through bioinformatics analysis. Therefore, further research using other types of immune and 
periodontal cells but also specific in vivo models of periodontitis (Graves et al., 2012) should 
pave the way for a better understanding of their role in periodontal disease development and 
to identify their potential use as therapeutics. Their pivotal role in a network of cellular 
mechanisms may allow us to use them to target specifically well identified pathways with the 
aim to control infection related process. The development of specific carriers is mandatory to 
develop highly-selective miR based therapies.  
The focus of the second study was to test whether PGIcNAc material can produce a 
reliable alternative to BMP2 for bone formation. It is known that BMP2 has powerful bone 
regeneration capability and improves bone formation (Kim et al., 2014). BMP2 can induce 
ectopic bone formation if expressed at sufficient concentrations at ectopic locations (Tachi et 
al., 2011). BMP2 belongs to the TGF-β signaling pathway superfamily, which modulates the 
bone growth and skeletal development (Wang et al., 2014; Wu et al., 2016). As it was shown 
in X-ray analysis, histological measurements, and ALP activity staining. Namely, all methods 
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indicate that the addition of BMP2 was sufficient to induce bone formation in CSD. More 
importantly, BMP2 combination with the TM gel or sheet did not inhibit the strong effect of 
BMP2 to bone formation. We also noticed that the TM gel could work as a BMP2 carrier 
material. The physical form of the materials has been demonstrated to revel significant 
differences biologically. Size, shape and texture of a particular materials can play an important 
role in the biological response (Hansen et al., 2006; Mitragotri & Lahann, 2009). Importantly, 
in our study, the different physical forms of the same materials (TM gel, powder and sheet) 
did not shown increase of bone formation and did not affect the regenerated bone. This 
indicated that the materials can be safely used as a carrier for osteogenic mediators.  
Controversial uses of PRP in bone formation studies were reported in the literature. 
Many reports have indicated that the PRP enhanced bone formation (Albanese et al., 2013). 
Other reports showed that PRP was not sufficient to produce bone (Roldan et al., 2004; Sarkar 
et al., 2006). Our results support that PRP does not inhibit bone formation; however, PRP alone 
was unable to close the 5mm CSD. This may be due to the size of the defect induced in this 
study. Many reports have indicated that PRP is a better adjunct for soft tissue healing than for 
bone (Albanese et al., 2013). In addition, it has been reported that PRP could produce better 
results when combined with other materials (Albanese et al., 2013). 
 Multiple studies have also reported that L-PRF induced bone formation in humans and 
allowed for faster healing (Marenzi et al., 2015). Reports demonstrate that the use of L-PRF 
can reduce post-surgical pain and enhance soft tissue healing (Munoz et al., 2016). L-PRF was 
also indicated for enhanced osseointegration after dental implant placement (Öncü et al., 
2016). Our data support that L-PRF did not inhibit bone healing; however, it was not sufficient 
to close the 5mm CSD. This result may be due to the defect size we used in this study. 
Additionally, L-PRF, as indicated by many studies, is more suited for combined hard and soft 
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tissue healing instead of CSD regeneration (Marenzi et al., 2015; Munoz et al., 2016; Öncü et 
al., 2016). This desired effect may be attributed to its use in the oral cavity, where improved 
blood circulations and sub-critical size bone defect exist. 
 Results in this study suggest that PGIcNAc material is bone friendly. PGIcNAc can 
merge with the newly formed bone and would not interfere with or inhibit new bone formation 
in any physical form. Regardless of the physical form, sheet, powder or gel, PGIcNAc was 
able to be incorporate within the bone. This indicates that the material can serve as a good 
candidate for osteogenic substances. Multiple publications have proposed that PGIcNAc 
material could be used as a blood clotting agent via the induction of platelets, red blood cells 
aggregations and aiding endothelial cell formation (Ikeda et al., 2002; Thatte et al., 2004; 
Thatte et al., 2004). It also suggested that the PGIcNAc can help the prevention of bleeding 
due to varicose veins in animal study (Kulling et al., 1999). Another important use of the 
material is in antibiotic resistance, detergent resistance, and biofilm forming perio-pathogen 
(Izano et al., 2007; Izano et al., 2008; Choi et al., 2009). However, no reports have suggested 
that this material could aid in osteogenic formation. Our study demonstrated that the PGIcNAc 
does not possess any osteogenic property. However, we did demonstrate that this material can 
be utilized as a carrier for osteogenic substances due to its bone compatibility.  
 Future studies utilizing a higher viscosity gel form of TM (PGIcNAc) in combination 
with osteogenic substances may produce a reliable, non-toxic, and non-carcinogenic bone 
substitute.    
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